Parenteral Drugs (India) Limited, a active public limited company, was established on 13 December 1983 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: L24100MH1983PLC126481. Registered under ROC Roc Mumbai. it is listed on BSE: 524689 and NSE: PDPL. It has an authorized capital of ₹50.00 Cr and a paid-up capital of ₹29.82 Cr.
Formerly known as Parenteral Drugs (India) Private Limited. It upholds a compliant status. Employing 610 professional, Its leadership includes Manish Verma (Director), Anil Mittal (Director), Vinod Kumar Gupta (Managing Director). Past directors included Sandeep Vyas, Manish Verma, Manohar Lal Gupta. It holds ₹547.55 Cr open charges and ₹96.32 Cr settled loans. Its latest AGM occurred on 24 September 2021, with the balance sheet filed on 31 March 2021. It is based at E/210, 2Nd Floor, Crystal Plaza, Off New Link Road Andheri West, Mumbai, Maharashtra, 400053.
L24100MH1983PLC126481
126481
13 December 1983
₹50.00 Cr
₹29.82 Cr
Roc Mumbai
Listed (BSE: 524689, NSE: PDPL)
Active
Explore comprehensive insights into Parenteral Drugs (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Manish Verma | Director | 29 Jun 2018 | Current |
| Anil Mittal | Director | 30 Jan 2008 | Current |
| Vinod Kumar Gupta | Managing Director | 24 Apr 2019 | Current |
| Kavish Vijayvargiya | Director | 19 Mar 2025 | Current |
| Chhaya Gupta | Director | 02 Feb 2022 | Current |
| Govind Sharma | Director | 19 Mar 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 13 Jun 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Managing Director | 31 Dec 2008 | Past |
| Pramod Abcsdd | Irp/Rp/Liquidator | 06 Mar 2025 | Past |
| Pramod Abcsdd | Nominee Director | 30 Jun 2014 | Past |
| Pramod Abcsdd | Whole-Time Director | 14 Aug 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Parenteral Drugs (India) Limited, for the financial year ended 2021, experienced significant reduction in revenue, with a 61.93% decrease. The company also saw a slight decrease in profitability, with a 6.7% decrease in profit. The company's net worth observed a substantial decline by a decrease of 21.65%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Parenteral Drugs (India) had a promoter holding of 73.28% and a public holding of 26.73%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹5,475,500,000.00
₹963,200,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Apr 2015 | Others | ₹95.63 Cr | Open |
| 21 Dec 2012 | Others | ₹56.50 Cr | Open |
| 26 Sep 2007 | Others | ₹15.28 Cr | Open |
| 26 Sep 2007 | Others | ₹5.80 M | Open |
| 12 Mar 2007 | Others | ₹7.60 M | Open |
Explore comprehensive loan charge details -
Parenteral Drugs (India) has a workforce of 610 employees as of Mar 28, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Parenteral Drugs (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Parenteral Drugs (India)'s trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Ashok Kumar Patidar was appointed as a Additional Director was appointed as a Additional Director on 17 Jul 2025 & has been associated with this company since 5 months 26 days . was completed.
Kavish Vijayvargiya was appointed as a Director was appointed as a Director on 19 Mar 2025 & has been associated with this company since 9 months 24 days . was recorded as a recent event.
The activity Govind Sharma was appointed as a Director was appointed as a Director on 19 Mar 2025 & has been associated with this company since 9 months 24 days . was completed.
The activity A charge with Others of Rs. 56.50 Cr registered on 21 Dec 2012 with Charge ID 10399402 was modified on 05 Feb 2024. was completed.
A charge with Others of Rs. 0.58 Cr registered on 26 Sep 2007 with Charge ID 10223861 was modified on 05 Feb 2024. was recorded as a recent event.
A charge with Others of Rs. 95.63 Cr registered on 07 Apr 2015 with Charge ID 10562129 was modified on 12 Oct 2023. was recorded as a recent event.
The CIN of Parenteral Drugs (India) Limited is L24100MH1983PLC126481.
Parenteral Drugs (India) Limited is headquartered at E/210, 2Nd Floor, Crystal Plaza, Off New Link Road Andheri West, Mumbai, Maharashtra, 400053.
Parenteral Drugs (India) Limited was incorporated on 13 December 1983.
The current directors of Parenteral Drugs (India) Limited are
The primary industry of Parenteral Drugs (India) Limited is Manufacturing.
Parenteral Drugs (India) Limited is listed. It is listed on BSE: 524689 and NSE: PDPL.
The authorized capital of Parenteral Drugs (India) Limited is ₹50.00 Cr, and the paid-up capital is ₹29.82 Cr.
The compliance status of Parenteral Drugs (India) Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX